BNP Paribas Financial Markets’s Crescent Biopharma CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $65 | Sell |
|
|||||
|
2025
Q1 | $101 | Hold |
|
|||||
|
2024
Q4 | $120 | Hold |
|
|||||
|
2024
Q3 | $81 | Hold |
|
|||||
|
2024
Q2 | $135 | Hold |
|
|||||
|
2024
Q1 | $1.44K | Hold |
|
|||||
|
2023
Q4 | $1.14K | Hold |
|
|||||
|
2023
Q3 | $722 | Hold |
|
|||||
|
2023
Q2 | $837 | Hold |
|
|||||
|
2023
Q1 | $606 | Hold |
|
|||||
|
2022
Q4 | $1.46K | Hold |
|
|||||
|
2022
Q3 | $265 | Hold |
|
|||||
|
2022
Q2 | $288 | Hold |
|
|||||
|
2022
Q1 | $548 | Hold |
|
|||||
|
2021
Q4 | $693 | Hold |
|
|||||
|
2021
Q3 | $1.19K | Hold |
|
|||||
|
2021
Q2 | $1.26K | Sell |
|
|||||
|
2021
Q1 | $45.4K | Buy |
|
|||||
|
2020
Q4 | $26.5K | Sell |
|
|||||
|
2020
Q3 | $26.3K | Buy |
|
|||||
|
2020
Q2 | $6.87K | Sell |
|
|||||
|
2020
Q1 | $23.9K | Buy |
|
|||||
|
2019
Q4 | $20.9K | Sell |
|
|||||
|
2019
Q3 | $23.5K | Buy |
|
|||||
|
2019
Q2 | $45.4K | Sell |
|
|||||
|
2019
Q1 | $88.3K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $15.8K | Hold |
|
|||||
|
2018
Q2 | $17.7K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $1.01K | Hold |
|
|||||
|
2017
Q2 | $804 | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $5.37K | Buy |
|
|||||
|
2016
Q2 | $2.94K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $1.3K | Sell |
|
|||||
|
2014
Q2 | $4.96K | Buy |
|